Status:

COMPLETED

Natural History, Genetic Bases and Phenotype-genotype Correlations in Autosomal Dominant Spinocerebellar Degenerations

Lead Sponsor:

Institut National de la Santé Et de la Recherche Médicale, France

Collaborating Sponsors:

Assistance Publique - Hôpitaux de Paris

Conditions:

Spinocerebellar Ataxias

Spastic Paraplegias

Eligibility:

All Genders

18-80 years

Brief Summary

The autosomal dominant spinocerebellar degenerations are a highly heterogeneous, clinically and genetically, group of rare diseases and of severe evolution. So far, the responsible genes for less than...

Eligibility Criteria

Inclusion

  • Progressive ataxia or paraplegia,
  • Familial history of the disease (patients),
  • Over 18 years of age
  • No presentation of neurological or osteoarticular disorders

Exclusion

  • Refusal to participate in the protocol,
  • An unknown familial history,
  • Presenting with an interrecurrent disorder making the evaluation of the disease (stroke, dementia) impossible

Key Trial Info

Start Date :

May 1 2005

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

May 1 2020

Estimated Enrollment :

175 Patients enrolled

Trial Details

Trial ID

NCT00136630

Start Date

May 1 2005

End Date

May 1 2020

Last Update

August 25 2021

Active Locations (8)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (8 locations)

1

Hôpital Pellegrin

Bordeaux, France, 33000

2

CHU de Grenoble

Grenoble, France, 38000

3

Hôpital Neurologique Pierre Wertheimer

Lyon, France, 69003

4

Hôpital La Timone

Marseille, France, 13005